nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—SHBG—hypothyroidism	0.573	1	CbGaD
Medroxyprogesterone Acetate—CYP2C8—Levothyroxine—hypothyroidism	0.0635	0.42	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Liotrix—hypothyroidism	0.062	0.41	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Levothyroxine—hypothyroidism	0.0258	0.17	CbGbCtD
Medroxyprogesterone Acetate—PGR—corpus luteum—hypothyroidism	0.0102	0.114	CbGeAlD
Medroxyprogesterone Acetate—SHBG—seminiferous tubule of testis—hypothyroidism	0.00964	0.107	CbGeAlD
Medroxyprogesterone Acetate—AR—seminiferous tubule of testis—hypothyroidism	0.00692	0.0767	CbGeAlD
Medroxyprogesterone Acetate—Benign intracranial hypertension—Levothyroxine—hypothyroidism	0.00444	0.0351	CcSEcCtD
Medroxyprogesterone Acetate—Benign intracranial hypertension—Dextrothyroxine—hypothyroidism	0.00444	0.0351	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Glucocorticoid biosynthesis—POMC—hypothyroidism	0.00389	0.0694	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperthyroidism—Levothyroxine—hypothyroidism	0.0033	0.0261	CcSEcCtD
Medroxyprogesterone Acetate—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.0033	0.0261	CcSEcCtD
Medroxyprogesterone Acetate—Benign intracranial hypertension—Liotrix—hypothyroidism	0.00326	0.0258	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—adrenal cortex—hypothyroidism	0.00311	0.0345	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—Androgen biosynthesis—POMC—hypothyroidism	0.00302	0.0538	CbGpPWpGaD
Medroxyprogesterone Acetate—Clotting—Liotrix—hypothyroidism	0.00269	0.0212	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—gonad—hypothyroidism	0.00257	0.0285	CbGeAlD
Medroxyprogesterone Acetate—PGR—Nuclear Receptors—THRA—hypothyroidism	0.00256	0.0456	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—pituitary gland—hypothyroidism	0.00251	0.0278	CbGeAlD
Medroxyprogesterone Acetate—Hyperthyroidism—Liotrix—hypothyroidism	0.00243	0.0192	CcSEcCtD
Medroxyprogesterone Acetate—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.00236	0.0186	CcSEcCtD
Medroxyprogesterone Acetate—Menstruation irregular—Levothyroxine—hypothyroidism	0.00236	0.0186	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—adrenal gland—hypothyroidism	0.00224	0.0249	CbGeAlD
Medroxyprogesterone Acetate—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00213	0.0168	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—female gonad—hypothyroidism	0.00209	0.0232	CbGeAlD
Medroxyprogesterone Acetate—PGR—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00202	0.0361	CbGpPWpGaD
Medroxyprogesterone Acetate—Abdominal bloating—Liotrix—hypothyroidism	0.00201	0.0159	CcSEcCtD
Medroxyprogesterone Acetate—AR—Nongenotropic Androgen signaling—SHBG—hypothyroidism	0.00195	0.0348	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Nuclear Receptors—THRA—hypothyroidism	0.00195	0.0348	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—urine—hypothyroidism	0.00193	0.0214	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—urine—hypothyroidism	0.00192	0.0213	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—testis—hypothyroidism	0.00186	0.0206	CbGeAlD
Medroxyprogesterone Acetate—Hypernatraemia—Liotrix—hypothyroidism	0.00182	0.0144	CcSEcCtD
Medroxyprogesterone Acetate—Venous thrombosis—Liotrix—hypothyroidism	0.00178	0.014	CcSEcCtD
Medroxyprogesterone Acetate—Menstruation irregular—Liotrix—hypothyroidism	0.00173	0.0137	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Nuclear Receptors—THRB—hypothyroidism	0.00165	0.0294	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.00164	0.0292	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00154	0.0275	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Nuclear Receptors—THRA—hypothyroidism	0.0015	0.0268	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptors—THRA—hypothyroidism	0.00148	0.0264	CbGpPWpGaD
Medroxyprogesterone Acetate—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00146	0.0116	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—urine—hypothyroidism	0.00146	0.0162	CbGeAlD
Medroxyprogesterone Acetate—Myocardial infarction—Liothyronine—hypothyroidism	0.00146	0.0115	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—nerve—hypothyroidism	0.00133	0.0148	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—adrenal cortex—hypothyroidism	0.00131	0.0145	CbGeAlD
Medroxyprogesterone Acetate—PGR—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0013	0.0232	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—heart—hypothyroidism	0.00127	0.0141	CbGeAlD
Medroxyprogesterone Acetate—AR—Nuclear Receptors—THRB—hypothyroidism	0.00126	0.0224	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.00125	0.0223	CbGpPWpGaD
Medroxyprogesterone Acetate—Coagulopathy—Liotrix—hypothyroidism	0.00123	0.00974	CcSEcCtD
Medroxyprogesterone Acetate—Necrosis—Liotrix—hypothyroidism	0.00122	0.00966	CcSEcCtD
Medroxyprogesterone Acetate—Abscess—Liotrix—hypothyroidism	0.00121	0.00958	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00119	0.0212	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00117	0.0208	CbGpPWpGaD
Medroxyprogesterone Acetate—Tenderness—Liotrix—hypothyroidism	0.0011	0.00869	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—pituitary gland—hypothyroidism	0.00106	0.0117	CbGeAlD
Medroxyprogesterone Acetate—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00104	0.00825	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00104	0.00825	CcSEcCtD
Medroxyprogesterone Acetate—Ulcer—Liotrix—hypothyroidism	0.00101	0.00802	CcSEcCtD
Medroxyprogesterone Acetate—Increased appetite—Levothyroxine—hypothyroidism	0.00101	0.00796	CcSEcCtD
Medroxyprogesterone Acetate—Increased appetite—Dextrothyroxine—hypothyroidism	0.00101	0.00796	CcSEcCtD
Medroxyprogesterone Acetate—AR—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.000992	0.0177	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00097	0.00767	CcSEcCtD
Medroxyprogesterone Acetate—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00097	0.00767	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Nuclear Receptors—THRB—hypothyroidism	0.000967	0.0173	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptors—THRB—hypothyroidism	0.000953	0.017	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—adrenal gland—hypothyroidism	0.000947	0.0105	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—blood—hypothyroidism	0.000946	0.0105	CbGeAlD
Medroxyprogesterone Acetate—Affect lability—Levothyroxine—hypothyroidism	0.000932	0.00736	CcSEcCtD
Medroxyprogesterone Acetate—Affect lability—Dextrothyroxine—hypothyroidism	0.000932	0.00736	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Liothyronine—hypothyroidism	0.000925	0.00731	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—thyroid gland—hypothyroidism	0.000913	0.0101	CbGeAlD
Medroxyprogesterone Acetate—Fluid retention—Liotrix—hypothyroidism	0.000911	0.0072	CcSEcCtD
Medroxyprogesterone Acetate—Irritability—Levothyroxine—hypothyroidism	0.000903	0.00714	CcSEcCtD
Medroxyprogesterone Acetate—Irritability—Dextrothyroxine—hypothyroidism	0.000903	0.00714	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—cardiovascular system—hypothyroidism	0.0009	0.00998	CbGeAlD
Medroxyprogesterone Acetate—Mood swings—Dextrothyroxine—hypothyroidism	0.000897	0.00709	CcSEcCtD
Medroxyprogesterone Acetate—Mood swings—Levothyroxine—hypothyroidism	0.000897	0.00709	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.000888	0.0158	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypotension—Liothyronine—hypothyroidism	0.000885	0.007	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—female gonad—hypothyroidism	0.000883	0.00979	CbGeAlD
Medroxyprogesterone Acetate—PGR—heart—hypothyroidism	0.000859	0.00952	CbGeAlD
Medroxyprogesterone Acetate—Muscular weakness—Levothyroxine—hypothyroidism	0.000835	0.0066	CcSEcCtD
Medroxyprogesterone Acetate—Muscular weakness—Dextrothyroxine—hypothyroidism	0.000835	0.0066	CcSEcCtD
Medroxyprogesterone Acetate—Sepsis—Liotrix—hypothyroidism	0.000832	0.00658	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Levothyroxine—hypothyroidism	0.000818	0.00647	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Dextrothyroxine—hypothyroidism	0.000818	0.00647	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—gonad—hypothyroidism	0.000817	0.00905	CbGeAlD
Medroxyprogesterone Acetate—PGR—cardiovascular system—hypothyroidism	0.00081	0.00899	CbGeAlD
Medroxyprogesterone Acetate—Sweating increased—Levothyroxine—hypothyroidism	0.000797	0.0063	CcSEcCtD
Medroxyprogesterone Acetate—Sweating increased—Dextrothyroxine—hypothyroidism	0.000797	0.0063	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—pituitary gland—hypothyroidism	0.000797	0.00883	CbGeAlD
Medroxyprogesterone Acetate—Swelling—Liotrix—hypothyroidism	0.000789	0.00624	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—testis—hypothyroidism	0.000783	0.00868	CbGeAlD
Medroxyprogesterone Acetate—Cardiac failure congestive—Liotrix—hypothyroidism	0.000768	0.00607	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.000764	0.0136	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.000758	0.0135	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.000753	0.0134	CbGpPWpGaD
Medroxyprogesterone Acetate—Body temperature increased—Liothyronine—hypothyroidism	0.000749	0.00592	CcSEcCtD
Medroxyprogesterone Acetate—Increased appetite—Liotrix—hypothyroidism	0.000741	0.00586	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—liver—hypothyroidism	0.00074	0.00821	CbGeAlD
Medroxyprogesterone Acetate—Weight decreased—Levothyroxine—hypothyroidism	0.00074	0.00585	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Dextrothyroxine—hypothyroidism	0.00074	0.00585	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—cerebellum—hypothyroidism	0.000723	0.00802	CbGeAlD
Medroxyprogesterone Acetate—PGR—Nuclear signaling by ERBB4—PRL—hypothyroidism	0.000721	0.0129	CbGpPWpGaD
Medroxyprogesterone Acetate—Fluoxymesterone—SHBG—hypothyroidism	0.00072	0.233	CrCbGaD
Medroxyprogesterone Acetate—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.000719	0.00568	CcSEcCtD
Medroxyprogesterone Acetate—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.000719	0.00568	CcSEcCtD
Medroxyprogesterone Acetate—PGR—pituitary gland—hypothyroidism	0.000718	0.00796	CbGeAlD
Medroxyprogesterone Acetate—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.000715	0.00565	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Levothyroxine—hypothyroidism	0.000715	0.00565	CcSEcCtD
Medroxyprogesterone Acetate—Hypoglycaemia—Liotrix—hypothyroidism	0.000713	0.00564	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—adrenal gland—hypothyroidism	0.000712	0.00789	CbGeAlD
Medroxyprogesterone Acetate—SHBG—blood—hypothyroidism	0.000712	0.00789	CbGeAlD
Medroxyprogesterone Acetate—Cerebrovascular accident—Liotrix—hypothyroidism	0.00071	0.00562	CcSEcCtD
Medroxyprogesterone Acetate—AR—adrenal cortex—hypothyroidism	0.000708	0.00785	CbGeAlD
Medroxyprogesterone Acetate—Sweating—Dextrothyroxine—hypothyroidism	0.000699	0.00553	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Levothyroxine—hypothyroidism	0.000699	0.00553	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—thyroid gland—hypothyroidism	0.000687	0.00761	CbGeAlD
Medroxyprogesterone Acetate—Affect lability—Liotrix—hypothyroidism	0.000685	0.00542	CcSEcCtD
Medroxyprogesterone Acetate—AR—heart—hypothyroidism	0.000684	0.00759	CbGeAlD
Medroxyprogesterone Acetate—ESR1—heart—hypothyroidism	0.000672	0.00745	CbGeAlD
Medroxyprogesterone Acetate—Irritability—Liotrix—hypothyroidism	0.000665	0.00525	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—female gonad—hypothyroidism	0.000664	0.00736	CbGeAlD
Medroxyprogesterone Acetate—Mood swings—Liotrix—hypothyroidism	0.00066	0.00521	CcSEcCtD
Medroxyprogesterone Acetate—Spironolactone—SHBG—hypothyroidism	0.000659	0.213	CrCbGaD
Medroxyprogesterone Acetate—Blood creatinine increased—Liotrix—hypothyroidism	0.000652	0.00516	CcSEcCtD
Medroxyprogesterone Acetate—AR—cardiovascular system—hypothyroidism	0.000646	0.00716	CbGeAlD
Medroxyprogesterone Acetate—AR—Notch-mediated HES/HEY network—BGLAP—hypothyroidism	0.000642	0.0114	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—adrenal gland—hypothyroidism	0.000641	0.00711	CbGeAlD
Medroxyprogesterone Acetate—PGR—blood—hypothyroidism	0.000641	0.00711	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cardiovascular system—hypothyroidism	0.000634	0.00703	CbGeAlD
Medroxyprogesterone Acetate—Hypokalaemia—Liotrix—hypothyroidism	0.000634	0.00501	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00063	0.0112	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—NKX2-1—hypothyroidism	0.000627	0.0112	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—thyroid gland—hypothyroidism	0.000619	0.00686	CbGeAlD
Medroxyprogesterone Acetate—Muscular weakness—Liotrix—hypothyroidism	0.000614	0.00485	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal distension—Liotrix—hypothyroidism	0.000606	0.00479	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Liotrix—hypothyroidism	0.000602	0.00476	CcSEcCtD
Medroxyprogesterone Acetate—PGR—female gonad—hypothyroidism	0.000598	0.00663	CbGeAlD
Medroxyprogesterone Acetate—Bronchospasm—Liotrix—hypothyroidism	0.000592	0.00468	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—testis—hypothyroidism	0.000589	0.00653	CbGeAlD
Medroxyprogesterone Acetate—Sweating increased—Liotrix—hypothyroidism	0.000586	0.00463	CcSEcCtD
Medroxyprogesterone Acetate—AR—gonad—hypothyroidism	0.000586	0.0065	CbGeAlD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.000584	0.0104	CbGpPWpGaD
Medroxyprogesterone Acetate—Methyltestosterone—SHBG—hypothyroidism	0.000582	0.188	CrCbGaD
Medroxyprogesterone Acetate—Bronchitis—Liotrix—hypothyroidism	0.000579	0.00457	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Dextrothyroxine—hypothyroidism	0.000579	0.00457	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Levothyroxine—hypothyroidism	0.000579	0.00457	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—gonad—hypothyroidism	0.000575	0.00638	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.000575	0.0103	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—pituitary gland—hypothyroidism	0.000572	0.00634	CbGeAlD
Medroxyprogesterone Acetate—ESR1—pituitary gland—hypothyroidism	0.000561	0.00622	CbGeAlD
Medroxyprogesterone Acetate—Tension—Dextrothyroxine—hypothyroidism	0.000559	0.00442	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Levothyroxine—hypothyroidism	0.000559	0.00442	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—liver—hypothyroidism	0.000556	0.00617	CbGeAlD
Medroxyprogesterone Acetate—Nervousness—Levothyroxine—hypothyroidism	0.000554	0.00438	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Dextrothyroxine—hypothyroidism	0.000554	0.00438	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Corticotropin-releasing hormone—POMC—hypothyroidism	0.000552	0.00984	CbGpPWpGaD
Medroxyprogesterone Acetate—Weight decreased—Liotrix—hypothyroidism	0.000544	0.0043	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—cerebellum—hypothyroidism	0.000544	0.00603	CbGeAlD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000542	0.00966	CbGpPWpGaD
Medroxyprogesterone Acetate—Tremor—Levothyroxine—hypothyroidism	0.000534	0.00422	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Dextrothyroxine—hypothyroidism	0.000534	0.00422	CcSEcCtD
Medroxyprogesterone Acetate—PGR—testis—hypothyroidism	0.00053	0.00588	CbGeAlD
Medroxyprogesterone Acetate—Acute coronary syndrome—Liotrix—hypothyroidism	0.000529	0.00418	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Liotrix—hypothyroidism	0.000526	0.00416	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Dextrothyroxine—hypothyroidism	0.000524	0.00414	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Levothyroxine—hypothyroidism	0.000524	0.00414	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Levothyroxine—hypothyroidism	0.000521	0.00412	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Dextrothyroxine—hypothyroidism	0.000521	0.00412	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Liotrix—hypothyroidism	0.000514	0.00407	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—adrenal cortex—hypothyroidism	0.000512	0.00568	CbGeAlD
Medroxyprogesterone Acetate—AR—adrenal gland—hypothyroidism	0.000511	0.00566	CbGeAlD
Medroxyprogesterone Acetate—AR—blood—hypothyroidism	0.000511	0.00566	CbGeAlD
Medroxyprogesterone Acetate—Palpitations—Dextrothyroxine—hypothyroidism	0.000504	0.00398	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Levothyroxine—hypothyroidism	0.000504	0.00398	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—adrenal gland—hypothyroidism	0.000501	0.00556	CbGeAlD
Medroxyprogesterone Acetate—ESR1—blood—hypothyroidism	0.000501	0.00556	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—heart—hypothyroidism	0.000496	0.0055	CbGeAlD
Medroxyprogesterone Acetate—Convulsion—Levothyroxine—hypothyroidism	0.000494	0.0039	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Dextrothyroxine—hypothyroidism	0.000494	0.0039	CcSEcCtD
Medroxyprogesterone Acetate—AR—thyroid gland—hypothyroidism	0.000493	0.00546	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—heart—hypothyroidism	0.000492	0.00545	CbGeAlD
Medroxyprogesterone Acetate—PGR—cerebellum—hypothyroidism	0.00049	0.00543	CbGeAlD
Medroxyprogesterone Acetate—Arthralgia—Levothyroxine—hypothyroidism	0.000485	0.00384	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Dextrothyroxine—hypothyroidism	0.000485	0.00384	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.000485	0.00865	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—thyroid gland—hypothyroidism	0.000484	0.00536	CbGeAlD
Medroxyprogesterone Acetate—Anxiety—Levothyroxine—hypothyroidism	0.000484	0.00382	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Dextrothyroxine—hypothyroidism	0.000484	0.00382	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000478	0.00852	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—female gonad—hypothyroidism	0.000476	0.00528	CbGeAlD
Medroxyprogesterone Acetate—Confusional state—Levothyroxine—hypothyroidism	0.000469	0.00371	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Dextrothyroxine—hypothyroidism	0.000469	0.00371	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—cardiovascular system—hypothyroidism	0.000468	0.00519	CbGeAlD
Medroxyprogesterone Acetate—ESR1—female gonad—hypothyroidism	0.000468	0.00518	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—cardiovascular system—hypothyroidism	0.000464	0.00514	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—pituitary gland—hypothyroidism	0.000462	0.00513	CbGeAlD
Medroxyprogesterone Acetate—Shock—Dextrothyroxine—hypothyroidism	0.000458	0.00362	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Levothyroxine—hypothyroidism	0.000458	0.00362	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Dextrothyroxine—hypothyroidism	0.000454	0.00359	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Levothyroxine—hypothyroidism	0.000454	0.00359	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00045	0.00355	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00045	0.00355	CcSEcCtD
Medroxyprogesterone Acetate—Hydrocortisone—SHBG—hypothyroidism	0.000438	0.142	CrCbGaD
Medroxyprogesterone Acetate—Alopecia—Liotrix—hypothyroidism	0.000426	0.00336	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—gonad—hypothyroidism	0.000424	0.00471	CbGeAlD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000424	0.00335	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000424	0.00335	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Nuclear signaling by ERBB4—PRL—hypothyroidism	0.000423	0.00755	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—testis—hypothyroidism	0.000422	0.00468	CbGeAlD
Medroxyprogesterone Acetate—Insomnia—Levothyroxine—hypothyroidism	0.000421	0.00333	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Dextrothyroxine—hypothyroidism	0.000421	0.00333	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Levothyroxine—hypothyroidism	0.000415	0.00328	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000415	0.00328	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—testis—hypothyroidism	0.000415	0.0046	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—pituitary gland—hypothyroidism	0.000414	0.00459	CbGeAlD
Medroxyprogesterone Acetate—Flatulence—Liotrix—hypothyroidism	0.000413	0.00327	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—blood—hypothyroidism	0.000413	0.00458	CbGeAlD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000413	0.00736	CbGpPWpGaD
Medroxyprogesterone Acetate—Tension—Liotrix—hypothyroidism	0.000411	0.00325	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Liotrix—hypothyroidism	0.000411	0.00325	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Liotrix—hypothyroidism	0.000407	0.00322	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000406	0.00724	CbGpPWpGaD
Medroxyprogesterone Acetate—Fatigue—Levothyroxine—hypothyroidism	0.000401	0.00317	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Dextrothyroxine—hypothyroidism	0.000401	0.00317	CcSEcCtD
Medroxyprogesterone Acetate—AR—liver—hypothyroidism	0.000399	0.00443	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—IYD—hypothyroidism	0.000395	0.00704	CbGpPWpGaD
Medroxyprogesterone Acetate—Tremor—Liotrix—hypothyroidism	0.000393	0.0031	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—liver—hypothyroidism	0.000392	0.00435	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypothyroidism	0.000387	0.00691	CbGpPWpGaD
Medroxyprogesterone Acetate—Agitation—Liotrix—hypothyroidism	0.000385	0.00305	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Levothyroxine—hypothyroidism	0.000383	0.00303	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000383	0.00303	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Liotrix—hypothyroidism	0.000383	0.00303	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—cerebellum—hypothyroidism	0.000383	0.00425	CbGeAlD
Medroxyprogesterone Acetate—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00038	0.00301	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00038	0.00301	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Liotrix—hypothyroidism	0.000376	0.00297	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Liotrix—hypothyroidism	0.000371	0.00293	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—adrenal gland—hypothyroidism	0.00037	0.0041	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—blood—hypothyroidism	0.00037	0.0041	CbGeAlD
Medroxyprogesterone Acetate—Urticaria—Levothyroxine—hypothyroidism	0.00037	0.00292	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Dextrothyroxine—hypothyroidism	0.00037	0.00292	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Liotrix—hypothyroidism	0.000369	0.00291	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000368	0.00291	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000368	0.00291	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Levothyroxine—hypothyroidism	0.000368	0.00291	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Levothyroxine—hypothyroidism	0.000368	0.00291	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—blood—hypothyroidism	0.000367	0.00407	CbGeAlD
Medroxyprogesterone Acetate—Convulsion—Liotrix—hypothyroidism	0.000363	0.00287	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—thyroid gland—hypothyroidism	0.000357	0.00396	CbGeAlD
Medroxyprogesterone Acetate—Chest pain—Liotrix—hypothyroidism	0.000357	0.00282	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Liotrix—hypothyroidism	0.000357	0.00282	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—SHBG—hypothyroidism	0.000357	0.115	CrCbGaD
Medroxyprogesterone Acetate—Anxiety—Liotrix—hypothyroidism	0.000356	0.00281	CcSEcCtD
Medroxyprogesterone Acetate—AR—Coregulation of Androgen receptor activity—VAV3—hypothyroidism	0.000355	0.00634	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—THRA—hypothyroidism	0.000349	0.00623	CbGpPWpGaD
Medroxyprogesterone Acetate—Confusional state—Liotrix—hypothyroidism	0.000345	0.00273	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—female gonad—hypothyroidism	0.000345	0.00382	CbGeAlD
Medroxyprogesterone Acetate—Oedema—Liotrix—hypothyroidism	0.000342	0.0027	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Liotrix—hypothyroidism	0.000342	0.0027	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—testis—hypothyroidism	0.000342	0.00379	CbGeAlD
Medroxyprogesterone Acetate—Infection—Liotrix—hypothyroidism	0.00034	0.00269	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—SHBG—hypothyroidism	0.000337	0.109	CrCbGaD
Medroxyprogesterone Acetate—Shock—Liotrix—hypothyroidism	0.000337	0.00266	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ATP5O—hypothyroidism	0.000335	0.00598	CbGpPWpGaD
Medroxyprogesterone Acetate—Tachycardia—Liotrix—hypothyroidism	0.000334	0.00264	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Dextrothyroxine—hypothyroidism	0.000334	0.00264	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Levothyroxine—hypothyroidism	0.000334	0.00264	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Liotrix—hypothyroidism	0.000331	0.00261	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Levothyroxine—hypothyroidism	0.000329	0.0026	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Dextrothyroxine—hypothyroidism	0.000329	0.0026	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Liotrix—hypothyroidism	0.000326	0.00258	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—liver—hypothyroidism	0.000323	0.00358	CbGeAlD
Medroxyprogesterone Acetate—Hypotension—Liotrix—hypothyroidism	0.00032	0.00253	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000318	0.00252	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Levothyroxine—hypothyroidism	0.000318	0.00252	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000318	0.00567	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—TPO—hypothyroidism	0.000315	0.00563	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000313	0.00559	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.000312	0.00556	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000312	0.00246	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Liotrix—hypothyroidism	0.000309	0.00245	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000308	0.00549	CbGpPWpGaD
Medroxyprogesterone Acetate—Paraesthesia—Liotrix—hypothyroidism	0.000307	0.00243	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—testis—hypothyroidism	0.000306	0.00339	CbGeAlD
Medroxyprogesterone Acetate—Dyspnoea—Liotrix—hypothyroidism	0.000305	0.00241	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Liotrix—hypothyroidism	0.000297	0.00235	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Levothyroxine—hypothyroidism	0.000296	0.00234	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Dextrothyroxine—hypothyroidism	0.000296	0.00234	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Liotrix—hypothyroidism	0.000295	0.00233	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Levothyroxine—hypothyroidism	0.000293	0.00232	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Dextrothyroxine—hypothyroidism	0.000293	0.00232	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Dextrothyroxine—hypothyroidism	0.000293	0.00232	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Levothyroxine—hypothyroidism	0.000293	0.00232	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Liotrix—hypothyroidism	0.000293	0.00231	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000292	0.00521	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Dextrothyroxine—hypothyroidism	0.000291	0.0023	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Levothyroxine—hypothyroidism	0.000291	0.0023	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—liver—hypothyroidism	0.000289	0.00321	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—liver—hypothyroidism	0.000287	0.00318	CbGeAlD
Medroxyprogesterone Acetate—ESR1—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.000285	0.00508	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—cerebellum—hypothyroidism	0.000283	0.00313	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—Circadian Clock—AVP—hypothyroidism	0.000282	0.00503	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Liotrix—hypothyroidism	0.000282	0.00223	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Liotrix—hypothyroidism	0.00028	0.00221	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—blood—hypothyroidism	0.00028	0.0031	CbGeAlD
Medroxyprogesterone Acetate—Nausea—Dextrothyroxine—hypothyroidism	0.000276	0.00218	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Levothyroxine—hypothyroidism	0.000276	0.00218	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Liotrix—hypothyroidism	0.000272	0.00215	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Liotrix—hypothyroidism	0.000271	0.00214	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Liotrix—hypothyroidism	0.000271	0.00214	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—THRA—hypothyroidism	0.000266	0.00474	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—ZNF764—hypothyroidism	0.000261	0.00465	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Liotrix—hypothyroidism	0.000252	0.00199	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000249	0.00444	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Liotrix—hypothyroidism	0.000246	0.00194	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—PRL—hypothyroidism	0.000243	0.00433	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Liotrix—hypothyroidism	0.000242	0.00191	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Liotrix—hypothyroidism	0.000234	0.00185	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.000232	0.00413	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.00023	0.0041	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Liotrix—hypothyroidism	0.000226	0.00179	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—THRB—hypothyroidism	0.000225	0.00401	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—liver—hypothyroidism	0.000219	0.00243	CbGeAlD
Medroxyprogesterone Acetate—Vomiting—Liotrix—hypothyroidism	0.000218	0.00172	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Liotrix—hypothyroidism	0.000216	0.00171	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Liotrix—hypothyroidism	0.000216	0.0017	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Liotrix—hypothyroidism	0.000214	0.00169	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—THRA—hypothyroidism	0.000205	0.00365	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Liotrix—hypothyroidism	0.000203	0.00161	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—THRA—hypothyroidism	0.000202	0.0036	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—ZNF764—hypothyroidism	0.000199	0.00354	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—IYD—hypothyroidism	0.000195	0.00348	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00019	0.00338	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—THRB—hypothyroidism	0.000171	0.00306	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—THRA—hypothyroidism	0.000168	0.003	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ATP5O—hypothyroidism	0.000166	0.00296	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000162	0.00288	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—TPO—hypothyroidism	0.000156	0.00278	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—ZNF764—hypothyroidism	0.000153	0.00273	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ZNF764—hypothyroidism	0.000151	0.00269	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—TSHB—hypothyroidism	0.000146	0.0026	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000146	0.0026	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000144	0.00257	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000144	0.00256	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PRL—hypothyroidism	0.000143	0.00254	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.000136	0.00243	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—THRB—hypothyroidism	0.000132	0.00236	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PIK3C2A—hypothyroidism	0.00013	0.00232	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—THRB—hypothyroidism	0.00013	0.00232	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000128	0.00229	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—THRA—hypothyroidism	0.000128	0.00228	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000123	0.00219	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NKX2-5—hypothyroidism	0.00012	0.00214	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—SLC5A5—hypothyroidism	0.000109	0.00195	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—THRB—hypothyroidism	0.000108	0.00193	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000108	0.00192	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—THRA—hypothyroidism	9.86e-05	0.00176	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—THRA—hypothyroidism	9.72e-05	0.00173	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NKX2-5—hypothyroidism	9.12e-05	0.00163	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IGF1—hypothyroidism	9.06e-05	0.00162	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	8.78e-05	0.00157	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	8.78e-05	0.00157	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	8.74e-05	0.00156	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—THRB—hypothyroidism	8.25e-05	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CLTC—hypothyroidism	7.83e-05	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—TSHB—hypothyroidism	7.21e-05	0.00129	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.11e-05	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NKX2-5—hypothyroidism	7.03e-05	0.00125	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NKX2-5—hypothyroidism	6.92e-05	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TRH—hypothyroidism	6.77e-05	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	6.76e-05	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PIK3C2A—hypothyroidism	6.43e-05	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—THRB—hypothyroidism	6.36e-05	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.34e-05	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—THRB—hypothyroidism	6.26e-05	0.00112	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CLTC—hypothyroidism	6.17e-05	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TSHB—hypothyroidism	6.03e-05	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TSHR—hypothyroidism	6.03e-05	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.79e-05	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—POMC—hypothyroidism	5.72e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PRL—hypothyroidism	5.69e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—IYD—hypothyroidism	5.48e-05	0.000977	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—SLC5A5—hypothyroidism	5.4e-05	0.000963	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SH2B3—hypothyroidism	5.37e-05	0.000959	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TRH—hypothyroidism	5.34e-05	0.000952	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TSHB—hypothyroidism	4.76e-05	0.000849	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TSHR—hypothyroidism	4.76e-05	0.000849	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.69e-05	0.000837	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ATP5O—hypothyroidism	4.66e-05	0.000831	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—POMC—hypothyroidism	4.64e-05	0.000828	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—IYD—hypothyroidism	4.46e-05	0.000795	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TPO—hypothyroidism	4.38e-05	0.000781	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SH2B3—hypothyroidism	4.24e-05	0.000756	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.06e-05	0.000724	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PRL—hypothyroidism	3.99e-05	0.000711	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ATP5O—hypothyroidism	3.79e-05	0.000676	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—POMC—hypothyroidism	3.78e-05	0.000674	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VAV3—hypothyroidism	3.69e-05	0.000658	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CLTC—hypothyroidism	3.62e-05	0.000646	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TPO—hypothyroidism	3.56e-05	0.000636	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AVP—hypothyroidism	3.55e-05	0.000634	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.3e-05	0.000589	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PRL—hypothyroidism	3.15e-05	0.000561	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TRH—hypothyroidism	3.13e-05	0.000559	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—IYD—hypothyroidism	2.94e-05	0.000525	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VAV3—hypothyroidism	2.91e-05	0.000519	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—POMC—hypothyroidism	2.82e-05	0.000504	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AVP—hypothyroidism	2.8e-05	0.0005	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TSHB—hypothyroidism	2.79e-05	0.000498	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TSHR—hypothyroidism	2.79e-05	0.000498	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.5e-05	0.000446	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.49e-05	0.000445	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SH2B3—hypothyroidism	2.49e-05	0.000444	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—POMC—hypothyroidism	2.36e-05	0.000421	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TPO—hypothyroidism	2.35e-05	0.000419	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IGF1—hypothyroidism	2.27e-05	0.000405	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TSHB—hypothyroidism	2.03e-05	0.000362	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—POMC—hypothyroidism	1.86e-05	0.000332	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRL—hypothyroidism	1.85e-05	0.000329	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	1.81e-05	0.000322	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF1—hypothyroidism	1.79e-05	0.00032	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.78e-05	0.000318	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VAV3—hypothyroidism	1.71e-05	0.000305	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TSHB—hypothyroidism	1.65e-05	0.000294	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AVP—hypothyroidism	1.65e-05	0.000294	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC5A5—hypothyroidism	1.52e-05	0.000271	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	1.47e-05	0.000262	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.45e-05	0.000259	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC5A5—hypothyroidism	1.24e-05	0.00022	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—POMC—hypothyroidism	1.09e-05	0.000195	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TSHB—hypothyroidism	1.09e-05	0.000194	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1—hypothyroidism	1.05e-05	0.000188	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	9.7e-06	0.000173	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC5A5—hypothyroidism	8.15e-06	0.000145	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—POMC—hypothyroidism	7.94e-06	0.000142	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—POMC—hypothyroidism	6.46e-06	0.000115	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—POMC—hypothyroidism	4.26e-06	7.6e-05	CbGpPWpGaD
